Merck shares jump after Citi upgrade on stronger cancer drug sales
October 18, 2017 at 09:03 AM EDT
Keytruda is an immunotherapy drug used in cancer treatments. Citi increased its peak Keytruda sales forecast on the drug to $16 billion from $9 billion.
